Hemoglobin A1c as a Surrogate for Clinical Outcomes in Diabetes Studies.

Abstract

Hemoglobin A1c as a Surrogate for Clinical Outcomes in Diabetes Studies To the Editor In a Viewpoint article, Drs Lipska and Krumholz1 discussed the role of hemoglobin A1c (HbA1c) and how its incorporation into clinical guidelines and clinical trials is evolving. There is growing evidence that using glycemic control as a surrogate for preventing adverse… (More)
DOI: 10.1001/jama.2017.7222

Topics

Cite this paper

@article{Venker2017HemoglobinAA, title={Hemoglobin A1c as a Surrogate for Clinical Outcomes in Diabetes Studies.}, author={Brett T Venker}, journal={JAMA}, year={2017}, volume={318 2}, pages={200} }